0001193125-22-177034.txt : 20220621 0001193125-22-177034.hdr.sgml : 20220621 20220621070603 ACCESSION NUMBER: 0001193125-22-177034 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220615 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220621 DATE AS OF CHANGE: 20220621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Karuna Therapeutics, Inc. CENTRAL INDEX KEY: 0001771917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270605902 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38958 FILM NUMBER: 221026013 BUSINESS ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 857-449-2244 MAIL ADDRESS: STREET 1: 99 HIGH STREET STREET 2: 26TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 8-K 1 d353681d8k.htm 8-K 8-K
false 0001771917 0001771917 2022-06-15 2022-06-15

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 15, 2022

 

 

KARUNA THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-38958   27-0605902

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

99 High Street, Floor 26

Boston, Massachusetts

  02110
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (857) 449-2244

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common stock, par value $0.0001   KRTX   The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders

Karuna Therapeutics, Inc. (the “Company”) held its previously announced Annual Meeting of Stockholders (the “Annual Meeting”) on June 15, 2022, at which a quorum was present. As of April 18, 2022, the record date for the Annual Meeting, there were 29,876,483 shares of the Company’s common stock outstanding and entitled to vote at the Annual Meeting. The Company’s stockholders voted on the following matters, which are described in detail in the Company’s Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission on April 27, 2022: (i) to elect Steven Paul, M.D., Atul Pande, M.D. and Denice Torres as Class III directors of the Company, each to serve for a three-year term expiring at the Company’s annual meeting of stockholders in 2025 or until his or her successor has been duly elected and qualified (“Proposal 1”), (ii) to approve, on an advisory basis, the compensation paid to the Company’s named executive officers (“Proposal 2”), (iii) to approve, on an advisory basis, the frequency of future advisory votes on the compensation paid to the Company’s named executive officers (“Proposal 3”), and (iv) to ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 (“Proposal 4”).

Proposal 1 – Election of Directors

The Company’s stockholders approved the Class III director nominees recommended for election in Proposal 1 at the Annual Meeting. The Company’s stockholders voted for the Class III directors as follows:

 

Name

   Votes For      Votes Withheld      Broker Non-Votes  

Steven Paul, M.D.

     23,277,049        3,900,919        1,856,158  
  

 

 

    

 

 

    

 

 

 

Atul Pande, M.D.

     23,058,840        4,119,128        1,856,158  
  

 

 

    

 

 

    

 

 

 

Jeffrey Jonas, M.D.

     22,375,830        4,802,138        1,856,158  
  

 

 

    

 

 

    

 

 

 

Proposal 2 – Advisory vote on the compensation paid to the Company’s named executive officers

The Company’s stockholder’s approved, on an advisory basis, the compensation paid to the Company’s named executive officers. The votes cast at the Annual Meeting were as follows:

 

Votes For

 

Votes Against

 

Abstain

 

Broker Non-Votes

21,124,063   5,639,878   414,027   1,856,158

 

 

 

 

 

 

 

Proposal 3 – Advisory vote on the frequency of future advisory votes on the compensation paid to the Company’s named executive officers

The votes cast at the Annual Meeting were as follows:

 

1 Year

 

2 Years

 

3 Years

 

Abstain

 

Broker Non-Votes

26,157,158   33,050   572,248   415,512   1,856,158

 

 

 

 

 

 

 

 

 

The Company has considered the outcome of this advisory vote and has determined, as was recommended with respect to this proposal by the Company’s board of directors in the proxy statement for the Annual Meeting, that the Company will hold future say on pay votes on an annual basis until the occurrence of the next advisory vote on the frequency of say on pay votes. The next advisory vote regarding the frequency of say on pay votes is required to occur no later than the Company’s 2028 annual meeting of stockholders.

Proposal 4 – Ratification of the Selection of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. The votes cast at the Annual Meeting were as follows:

 

Votes For

 

Votes Against

 

Abstain

29,028,736   2,498   2,892

 

 

 

 

 

No other matters were submitted to or voted on by the Company’s stockholders at the Annual Meeting.


Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

104    Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Karuna Therapeutics, Inc.
Date: June 21, 2022     By:  

    /s/ Troy Ignelzi

          Troy Ignelzi
          Chief Financial Officer
EX-101.SCH 2 krtx-20220615.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 krtx-20220615_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 krtx-20220615_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Document and Entity Information
Jun. 15, 2022
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001771917
Document Type 8-K
Document Period End Date Jun. 15, 2022
Entity Registrant Name KARUNA THERAPEUTICS, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-38958
Entity Tax Identification Number 27-0605902
Entity Address, Address Line One 99 High Street
Entity Address, Address Line Two Floor 26
Entity Address, City or Town Boston
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02110
City Area Code (857)
Local Phone Number 449-2244
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common stock, par value $0.0001
Trading Symbol KRTX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 d353681d8k_htm.xml IDEA: XBRL DOCUMENT 0001771917 2022-06-15 2022-06-15 false 0001771917 8-K 2022-06-15 KARUNA THERAPEUTICS, INC. DE 001-38958 27-0605902 99 High Street Floor 26 Boston MA 02110 (857) 449-2244 false false false false Common stock, par value $0.0001 KRTX NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d353681d8k.htm krtx-20220615.xsd krtx-20220615_lab.xml krtx-20220615_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d353681d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d353681d8k.htm" ] }, "labelLink": { "local": [ "krtx-20220615_lab.xml" ] }, "presentationLink": { "local": [ "krtx-20220615_pre.xml" ] }, "schema": { "local": [ "krtx-20220615.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "krtx", "nsuri": "http://karunatx.com/20220615", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d353681d8k.htm", "contextRef": "duration_2022-06-15_to_2022-06-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d353681d8k.htm", "contextRef": "duration_2022-06-15_to_2022-06-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://karunatx.com//20220615/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001193125-22-177034-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-177034-xbrl.zip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end